Theres a lot of things to like about BNO
with a compound that has serious efficacy about to go clinical, reasonable funding, firm alliances, some ongoing revenues - you'd have to think its one of the better biotechs and somewhat undervalued
wish I had tucked a few more away before sp came back to the 20s
Theres a lot of things to like about BNOwith a compound that has...
Add to My Watchlist
What is My Watchlist?